Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Barclays upgrades United Utilities, sees 'better prospects' for water sector

(Sharecast News) - Barclays upgraded United Utilities on Wednesday, saying it sees "better prospects" for the water sector amid an improving outlook, as it lifted price targets across all three big names. The bank said the Cunliffe Review should lead to a resilient, lower-risk sector and that capex will continue to rise with a focus shifting to water resilience, asset health and PFAS.

PFAs are a large family of synthetic chemicals used across a variety of applications due to their durability and resistance to heat, water, and oil.

Barclays also said that better performers should see returns ahead of requirement.

The bank upgraded UU to 'overweight' from 'equalweight' and lifted the price target to 1,535p from 1,280p. It said there was 35% upside to the PT.

"We believe UU to be an attractive value proposition," it said. "We estimate the group is trading at a cheap 10.0% premium to March 2026 RAB. If UU were to remain at a 10% premium to RCV by 2030, it would deliver circa 11.5% IRR through to 2030."

It kept Pennon at 'overweight', saying it was its "preferred" overweight in the sector, and upped the price target to 670p from 650p.

The bank left Severn Trent at 'equalweight' but hiked the price target to 3,385p from 2,960p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.